Prevalence of Hypertension and Diabetes in Children
Downloads
In 2017, the American Academy of Pediatrics issued a new clinical practice guideline for defining hypertension in children as an update to the previous Fourth Report guidelines issued in 2004. Prevalence of confirmed pediatric hypertension in children has ranged from 2% to 4% based on previous guidelines yet it is unknown what the prevalence is under the new guideline. We estimated the prevalence of elevated blood pressure, stage 1, and stage 2 hypertension by the new American Academy of Pediatrics guideline in our school-based blood pressure screening program. New prevalence estimates were compared with Fourth Report prevalence estimates in the same population by sex, age, and height factors. In 22 224 students aged 10 to 17 years screened in school as part of the Houston Pediatric and Hypertension Program at the University of Texas McGovern Medical School, the prevalence of elevated blood pressure (previously called prehypertension) increased from 14.8% by Fourth Report to 16.3% by the new American Academy of Pediatrics guideline. This increase in elevated blood pressure resulted from differential classification changes in younger and older children. Prevalence of confirmed hypertension remains at 2% to 4% in this population, however shorter children <13 years old and taller, older children 13+ years old are systematically more likely to be diagnosed with hypertension by new guidelines..
Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984;26:401–5. [PubMed] [Google Scholar]
Nørgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Saelan H, Deckert T. Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:407–10. [PubMed] [Google Scholar]
Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805. [PubMed] [Google Scholar]
Rodrigues TC, Canani LH, Viatroski RS, Hoffmann LH, Esteves JF, Gross JL. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract. 2010;87:240–5. [PubMed] [Google Scholar]
Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens. 2009;27:1719–42. [PubMed] [Google Scholar]
National High Blood Pressure Education Program ^ "Diabetes Mellitus in Children and Adolescents", www.msdmanuals.com, Retrieved November 16, 2018. Edited.
Karagiannis A, Mikhailidis DP, Tziomalos K, Kakafika AI, Athyros VG. Has the time come for a new definition of microalbuminuria? Curr Vasc Pharmacol. 2008;6:81–3. [PubMed] [Google Scholar]
Toto RD. Microalbuminuria: Definition, detection, and clinical significance. J Clin Hypertens (Greenwich) 2004;6:2–7. [PubMed] [Google Scholar]
Chiarelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol. 1995;9:154–8. [PubMed] [Google Scholar]
Helal I, Reed B, McFann K, Yan XD, Fick-Brosnahan GM, Cadnapaphornchai M, et al. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:2439–43. [PMC free article] [PubMed] [Google Scholar]
Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, et al. Derivation and validation of cystatin C-based prediction equations for GFR in children. Am J Kidney Dis. 2006;48:221–30. [PubMed] [Google Scholar]
Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant. 2012;27:1821–5. [PubMed] [Google Scholar]
Wilkinson IB, MacCallum H, Rooijmans DF, Murray GD, Cockcroft JR, McKnight JA, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441–8. [PubMed] [Google Scholar]
Suláková T, Janda J, Cerná J, Janštová V, Feber J. Assessment of arterial stiffness from ambulatory blood pressure monitoring in children with diabetes mellitus type-1 (DMT1) J Hum Hypertens. 2012;26:357–64. [PubMed] [Google Scholar]
Krause M, Rüdiger H, Bald M, Näke A, Paditz E. Autonomic blood pressure control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2009;10:255–63. [PubMed] [Google Scholar]
Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Ferholm K, Saraheimo M, et al. Metabolic syndrome in type 1 diabetes. Diabetes Care. 2005;28:2019–202. [PubMed] [Google Scholar]
Chen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine. 2009;36:262–7. [PubMed] [Google Scholar]
Raile K, Galler A, Hofer S, Herbst A, Dunstheimer D, Busch P, et al. Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care. 2007;30:2523–8. [PubMed] [Google Scholar]
Hooman N, Roohani F, Moradi S, Mobarra M, Najafizadeh M. Cystatin C as an early marker of diabetic nephropathy in children with Type 1 diabetes mellitus. Pediatr Nephrol. 2013;28:1533–689
Copyright (c) 2024 Hassan Razzaq Maktouf, Zainab Adnan Helal, Shahad Khalid Kadhim, Sattar Jabbar Javat, Duha Kareem Ahmed

This work is licensed under a Creative Commons Attribution 4.0 International License.














